Analysts count on revenue increase Novozymes

Tomorrow the Danish Novozymes will report its past quarters results. Over the current book year the total revenue will be 14,79 billion Danish Krone (consensus estimates). This is slightly more than 2018's revenue of 14,39 billion Danish Krone.

Historical revenues and results Novozymes plus estimates 2019

The analysts expect for 2019 a net profit of 3,29 billion Danish Krone. Most of the analysts anticipate on a profit per share of 11,5 Danish Krone. So the price/earnings-ratio equals 26,2.

Per share the analysts expect a dividend of 5,43 Danish Krone per share. Novozymes's dividend yield thus equals 1,8 percent. The average dividend yield of the chemical companies is a good 27 percent.

Novozymes's market capitalization is based on the number of outstanding shares around 72,07 billion Danish Krone. The Novozymes stock was the past 12 months quite volatile. Since last August the stock is 12 percent lower. This year the stock price moved between 260 and 363 DKK.

Historical stock prices Novozymes

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.